Study Description
This is a Phase I/II research study looking for the most effective dose, safety, and acceptability of a LNG (progestin only) patch. The study will compare the contraceptive effectiveness of two different doses of progestin (in a patch delivery system) by evaluating their affect on rates of ovulation and cervical mucus (fluids). The patch is considered investigational and not approved by the FDA as a contraceptive patch.
Study Requirements You must:
|